Artwork

Content provided by Marketplace. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Marketplace or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The sentence that helped set off the opioid crisis

1:05:19
 
Share
 

Manage episode 197402310 series 1318965
Content provided by Marketplace. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Marketplace or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When OxyContin went to market in 1996, sales reps from Purdue Pharma hit one point particularly hard: Compared to other prescription opioids, this new painkiller was believed to be less likely to be addictive or abused.

But recently unsealed documents in this investigative episode shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid crisis.

Welcome back to The Uncertain Hour. Where the things we fight the most about are the things we know the least about. Subscribe on your favorite podcast app.

  continue reading

57 episodes

Artwork
iconShare
 
Manage episode 197402310 series 1318965
Content provided by Marketplace. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Marketplace or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

When OxyContin went to market in 1996, sales reps from Purdue Pharma hit one point particularly hard: Compared to other prescription opioids, this new painkiller was believed to be less likely to be addictive or abused.

But recently unsealed documents in this investigative episode shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid crisis.

Welcome back to The Uncertain Hour. Where the things we fight the most about are the things we know the least about. Subscribe on your favorite podcast app.

  continue reading

57 episodes

Alle Folgen

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide